The most commonly reported adverse events in the Phase 2 trial were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation consistent with the GLP-1 receptor agonist class
It is not the same as being sick
How Employers Are Managing GLP-1 Coverage Rather than eliminating coverage altogether, many employers are implementing structured management strategies designed to balance access, affordability, and outcomes
A survey conducted in August found that more than 80% of Americans had heard at least a little bit about semaglutide, while about one-third had either tried it or expressed interest in doing so
During the night, your body is at rest, which gives the medication time to work without interfering with your daily activities
Understanding the patients individual food preferences, eating habits, and cultural background helps in developing a personalized meal plan